U.S. venture capital firms, METIS Innovative and ShangBay Capital, co-lead funding round and join board to accelerate company growth and development of unique bioabsorbable stent to cure brain aneurysms
Fluid Biotech Inc., a medical device start-up company in Calgary, Alberta, Canada, today announced the completion of its Seed fundraising round totaling $4.7 million USD and the addition of two new members to its board of directors. METIS Innovative of Miami, Florida, and ShangBay Capital of Palo Alto, California, co-led the company’s oversubscribed financing round, which included new investors UCeed Health Fund and UCeed Child Health and Wellness Fund from the University of Calgary, Thin Air Labs, Wharton Alumni Angels, Amino Capital, Bluesky Equities, ThresholdImpact and Alabaster Capital, and follow-on funding from pre-seed partners.